ATE161261T1 - Neue acylierte phospholipid-arzneimittel - Google Patents

Neue acylierte phospholipid-arzneimittel

Info

Publication number
ATE161261T1
ATE161261T1 AT93912305T AT93912305T ATE161261T1 AT E161261 T1 ATE161261 T1 AT E161261T1 AT 93912305 T AT93912305 T AT 93912305T AT 93912305 T AT93912305 T AT 93912305T AT E161261 T1 ATE161261 T1 AT E161261T1
Authority
AT
Austria
Prior art keywords
carbon atoms
hydrogen
hydrocarbyl
chain
group
Prior art date
Application number
AT93912305T
Other languages
English (en)
Inventor
Charles Pidgeon
Robert J Markovich
Original Assignee
Res Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Corp Technologies Inc filed Critical Res Corp Technologies Inc
Application granted granted Critical
Publication of ATE161261T1 publication Critical patent/ATE161261T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/117Esters of phosphoric acids with cycloaliphatic alcohols

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT93912305T 1992-04-16 1993-04-16 Neue acylierte phospholipid-arzneimittel ATE161261T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/869,697 US6602861B1 (en) 1992-04-16 1992-04-16 Acylated phospholipid drugs

Publications (1)

Publication Number Publication Date
ATE161261T1 true ATE161261T1 (de) 1998-01-15

Family

ID=25354097

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93912305T ATE161261T1 (de) 1992-04-16 1993-04-16 Neue acylierte phospholipid-arzneimittel

Country Status (7)

Country Link
US (2) US6602861B1 (de)
EP (1) EP0636134B1 (de)
AT (1) ATE161261T1 (de)
CA (1) CA2133444A1 (de)
DE (1) DE69315827T2 (de)
ES (1) ES2112421T3 (de)
WO (1) WO1993021191A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599947A (en) * 1993-01-14 1997-02-04 G. D. Searle & Co. Fatty acid analogs and prodrugs
US5859052A (en) * 1993-01-14 1999-01-12 G. D. Searle & Co. Fatty acid analogs and prodrugs
US5962437A (en) 1994-08-29 1999-10-05 Wake Forest University Lipid analogs for treating viral infections
US7135584B2 (en) 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
US6350472B1 (en) * 1998-12-14 2002-02-26 Steinbach, Pylant, And Hermann, L.L.C. Method of treating HIV infection with transdermal gel containing mammalian liver extract
AU2503900A (en) 1999-01-15 2000-08-01 Board Of Trustees Of The University Of Illinois, The Sulfated phosphatidylinositols, their preparation and use
US7026469B2 (en) 2000-10-19 2006-04-11 Wake Forest University School Of Medicine Compositions and methods of double-targeting virus infections and cancer cells
NO328803B1 (no) 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
US7659240B2 (en) * 2002-01-14 2010-02-09 Vertex Pharmaceuticals Incorporated Mucin immobilized chromatography
CN100351259C (zh) 2002-06-20 2007-11-28 Icvec有限公司 含硫的磷脂衍生物
CA2514126A1 (en) * 2003-01-22 2004-08-05 Encore Pharmaceuticals, Inc. Fat substitutes
EP2242495A2 (de) * 2008-01-16 2010-10-27 Technion Research and Development Foundation, Ltd. Verwendung antimikrobieller polymere zur resensibilisierung von mikroorganismen nach auftreten einer resistenz gegen antimikrobielle mittel
WO2011016043A2 (en) 2009-08-06 2011-02-10 Technion Research & Development Foundation Ltd. Antibiotic drug delivery and potentiation
BR112018077350A2 (pt) * 2016-06-29 2019-04-09 Machavert Pharmaceuticals Llc composições de fosfolipídio
WO2019208392A1 (ja) * 2018-04-27 2019-10-31 株式会社レオロジー機能食品研究所 新規プラズマローゲン誘導体

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4471113A (en) 1982-02-03 1984-09-11 The United States Of America As Represented By The Department Of Energy Prodrugs based on phospholipid-nucleoside conjugates
US5059591B1 (en) 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
JPS608948A (ja) * 1983-06-29 1985-01-17 Fujitsu Ltd 動作モ−ド検査方式
US4594193A (en) * 1984-09-26 1986-06-10 Research Corporation Thiol based lipids and membranes made therefrom
US4569794A (en) 1984-12-05 1986-02-11 Eli Lilly And Company Process for purifying proteins and compounds useful in such process
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
JPH068302B2 (ja) 1986-03-04 1994-02-02 財団法人生産開発科学研究所 重合性リン脂質化合物
DE3638687A1 (de) * 1986-11-13 1988-05-19 Lentia Gmbh Einstufiges verfahren zur herstellung von gemischt substituierten 1,2-di-acyl-sn-glycero-3-phosphocholinen
IL84387A0 (en) 1987-11-06 1990-02-09 Rapaport Erich Pharmaceutical compositions containing a substituted phosphatide
US5151445A (en) 1988-02-03 1992-09-29 Washington University Method of inhibiting parasitic activity
US4931498A (en) 1988-02-25 1990-06-05 Purdue Research Foundation Immobilized artificial membranes
US4927879A (en) 1988-02-25 1990-05-22 Purdue Research Foundation Method for solid phase membrane mimetics
US5073571A (en) 1988-06-16 1991-12-17 Washington University Method of inhibiting virus
US5082967A (en) 1988-06-16 1992-01-21 Washington University Novel fatty acid analog enzyme substrates
DE3929217A1 (de) 1989-09-02 1991-03-07 Boehringer Mannheim Gmbh Verwendung von phospholipid-derivaten als antivirale arzneimittel und neue phospholipide
SE463789B (sv) 1990-03-27 1991-01-21 Henrik Gerhard Renvall Saett att registrera, oeverfoera och lagra information med hjaelp av streckkoder
US5149527A (en) * 1990-09-18 1992-09-22 Oncotech, Inc. Immunopotentiating protocol for chemotherapy-responsive tumors

Also Published As

Publication number Publication date
DE69315827T2 (de) 1998-07-16
US5846955A (en) 1998-12-08
WO1993021191A1 (en) 1993-10-28
ES2112421T3 (es) 1998-04-01
DE69315827D1 (de) 1998-01-29
EP0636134B1 (de) 1997-12-17
EP0636134A1 (de) 1995-02-01
US6602861B1 (en) 2003-08-05
CA2133444A1 (en) 1993-10-28

Similar Documents

Publication Publication Date Title
ATE161261T1 (de) Neue acylierte phospholipid-arzneimittel
SE8201854L (sv) N-substituerade amino-aminosyror
NL960012I2 (nl) Gesubstitueerde acylderivaten van 1,2,3,4-tetrahydro-6,7-dimethoxy-3-isochinolinecarbonzuur.
ATE226821T1 (de) Verwendung von langkettigen n-alkyl derivaten von deoxynojirimycin zur herstellung eines medikaments zur behandlung von mit glykolipiden akkumulation zusammenhängenden krankheiten
FI87762C (fi) Fenylnaftalenderivat och kosmetiska kompositioner innehaollande dessa derivat
EA200000871A1 (ru) Ингибиторы фосфолипазных ферментов
ES2187025T3 (es) Nuevos agentes quelantes de hierro (iii) activos via oral.
ES2121084T3 (es) Utilizacion de derivados de terfenadina como antihistaminicos en un paciente que padece de trastornos hepaticos.
EP0467856A3 (en) Aminoalkanesulfonic acid derivatives and pharmaceutical compositions for use in preventing or treating heart diseases
SE9601677D0 (sv) New use
SE8204640L (sv) Aminosyraderivat
ATE33831T1 (de) Analgesia wirkende 5-hydroxytryptophan-derivate.
FR2549051B1 (fr) Nouveaux agents radioprotecteurs ayant une structure amino-thioalkyle et procede pour leur preparation
EA199800155A1 (ru) Новое соединение
KR870003107A (ko) 키산틴 유도체의 제조방법
MX9307510A (es) Un procedimiento para la preparacion de derivados de ester de acido fenilacetico.
EP0228314A3 (de) Verwendung von Äthanolamin-derivaten zur Behandlung oder Prävention von Hyperlipämie
DK0971899T3 (da) Hexahydroindenopyridinforbindelser med antispermatogen virkning
US2399506A (en) Aminoalkanols of arylacetic acids
ES2084725T3 (es) Nuevos derivados de ciclobutano.
ES2058315T3 (es) Compuestos eficaces contra insuficiencia cerebral.
JPS5573677A (en) Thienylbenzoic acid derivative and its production

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee